Երկիր: Թայվան
Լեզու: չինարեն
Աղբյուրը: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
FUROSEMIDE
賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356)
C03CA01
錠劑
FUROSEMIDE (4028000900) 40MG
鋁箔盒裝;;瓶裝
製 劑
須由醫師處方使用
HANDOK INC. 78, DAEPUNGSANDAN-RO, DAESO-MYEON, EUMSEONG-GUN, CHUNGCHEONGBUK-DO, KOREA KR
furosemide
利尿、高血壓。
有效日期: 2024/06/24; 英文品名: LASIX TABLETS 40MG
1999-06-24
1 LASIX ® TABLETS 40 MG Furosemide Sanofi Aventis COMPOSITION Each Lasix tablet contains 40mg furosemide. Excipients: lactose, corn starch, pregelatinized starch, colloidal silicon dioxide, talc, magnesium stearate THERAPEUTIC INDICATIONS Cardiac, hepatic and renal oedema (in the presence of nephrotic syndrome, treatment of the basic disorder is the prime concern). - Oedema due to burns. - Mild to moderate hypertension. DOSAGE AND ADMINISTRATION DOSAGE Unless otherwise prescribed by the doctor the following guideline apply: In adults treatment is usually begun with 1/2-1-2 tablets daily; maintenance dose: 1/2-1 tablet daily. In children furosemide is usually administered orally. Dosage recommendation: 2mg furosemide/kg bodyweight up to maximum of 40mg/day. ADMINISTRATION The duration of treatment is determined by the doctor. The tablets should be swallowed whole with some liquid. During long-term therapy blood creatinine and urea, as well as plasma electrolytes, especially potassium, calcium, chloride and bicarbonate should be regularly monitored. If this drug is used to treat hypertension, the patient must be regularly monitored by the doctor. CONTRAINDICATIONS LASIX must not be used - in patients with anuric renal failure not responding to furosemide. - in patients with pre-comatose and comatose states associated with hepatic encephalopathy. - in patients with severe hypokalaemia. - in patients with severe hyponatraemia. - in hypovolaemia patients with or without hypotension or dehydration. - In patients with hypersensitivity to furosemide or any of the excipients of LASIX. Patients allergic to sulfonamides(e.g. sulfonamide antibiotics or sulfonylureas) may show cross-sensitivity to furosemide. - in breast feeding women WARNINGS AND PRECAUTIONS ♦ Urinary outflow must be secured. In patients with a partial obstruction of urinary outflow (e.g. in patients with bladder-emptying disorders, prostatic hyperplasia or narrowing of the urethra), increased product of urine may provoke or aggravate complaints. Thus, th Կարդացեք ամբողջական փաստաթուղթը